NCT02386800 2026-03-16CINC424A2X01B Rollover ProtocolNovartisPhase 4 Active not recruiting279 enrolled
NCT03733249 2023-09-26Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical StudyBellicum PharmaceuticalsPhase 1/2 Terminated187 enrolled 8 charts